FDA Inspection 802926 — Daiichi Sankyo Co., Ltd.
The FDA completed an inspection of Daiichi Sankyo Co., Ltd. on Sep 20, 2012 in Chuo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 20, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chuo (Japan)
Additional Details
Postmarket Adverse Drug Experience (PADE)